Edwards Lifesciences Officer Andrew M. Dahl Files Form 144 to Sell $49.5K in Common Stock
Edwards Lifesciences Corp
Subscribe to track EW
Premium users can add ticker alerts and receive realtime notification updates.
Filing Summary
Proposed sale of 544 shares of Edwards Lifesciences Corp common stock valued at $49,534.00 by Officer Andrew M. Dahl on 08/31/2026.
Comprehensive Analysis
Executive Summary
On August 31, 2026, Andrew M. Dahl, an Officer of Edwards Lifesciences Corp ($EW), filed a Form 144 notice of proposed sale covering 544 shares of common stock with an aggregate market value of approximately $49,534.00.
Key Details
- Filer: Andrew M. Dahl (Officer)
- Issuer: Edwards Lifesciences Corp (CIK:
0001099800) - Shares to be Sold: 544 common shares
- Estimated Aggregate Market Value: $49,534.00 (~$91.06/share)
- Approximate Sale Date: August 31, 2026
- Broker: Charles Schwab & Co., Inc.
- Origin of Shares: Acquired on May 8, 2026, via restricted stock vesting / lapse as part of equity compensation.
- Prior 3-Month Sales: None reported.
Significance
The transaction represents a routine and low-value sale of equity compensation shares, posing Low market significance relative to Edwards Lifesciences' 576.4 million shares outstanding.
Get Real-Time Alerts
Join our community to receive instant notifications when high-significance filings are published
Important Disclaimer
This content is AI-generated from public SEC filings and may contain errors. It is for informational and educational purposes only and is not investment, legal, or tax advice.
The Filing Fool is not a registered investment adviser, broker-dealer, or financial planner. Nothing here is a recommendation or solicitation to buy, sell, or hold any security.
Always do your own due diligence and consult a licensed professional.